Article metrics


Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)

Statistics from

Online download statistics by month:

Online download statistics by month: January 2018 to March 2018

Jan 201812212223
Feb 2018431426114
Mar 201819619731